Oncomatryx Biopharma S.l.
Clinical trials sponsored by Oncomatryx Biopharma S.l., explained in plain language.
-
New hope for pancreatic cancer: targeted drug combo enters human testing
Disease control Recruiting nowThis early-phase trial is testing a new drug called OMTX705, which targets a protein on cancer cells, combined with standard chemotherapy and an immunotherapy for people with advanced pancreatic cancer that has spread. The study will enroll 69 participants to first find the safes…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new drug called OMTX705, which targets a protein found on cancer cells, either alone or with immunotherapy drugs (pembrolizumab or tislelizumab). The study includes 150 adults with advanced solid tumors who have no standard treatment options left. T…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC